Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
Eur J Pharmacol
    November 2023
  1. LI F, Qian LL, Wu LD, Zhang ZY, et al
    Glucose fluctuations aggravated the late sodium current induced ventricular arrhythmias via the activation of ROS/CaMKII pathway.
    Eur J Pharmacol. 2023 Nov 6:176167. doi: 10.1016/j.ejphar.2023.176167.
    >> Share

  2. YI Y, Tianxin Y, Zhangchi L, Cui Z, et al
    Pinocembrin attenuates susceptibility to atrial fibrillation in rats with pulmonary arterial hypertension.
    Eur J Pharmacol. 2023;960:176169.
    >> Share

    October 2023
  3. DE LIMA CONCEICAO MR, Teixeira-Fonseca JL, Marques LP, Souza DS, et al
    Interaction of the antiarrhythmic drug Amiodarone with the sodium channel Na(v)1.5 depends on the extracellular pH.
    Eur J Pharmacol. 2023 Oct 17:176127. doi: 10.1016/j.ejphar.2023.176127.
    >> Share

    May 2023
  4. LI Q, Fang Y, Peng DW, Li LA, et al
    Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats.
    Eur J Pharmacol. 2023 May 12:175754. doi: 10.1016/j.ejphar.2023.175754.
    >> Share

    January 2023
  5. LIU CM, Lin FJ, Chen YC, Lin YK, et al
    Modulation of post-pacing action potential duration and contractile responses on ventricular arrhythmogenesis in chloroquine-induced long QT syndrome.
    Eur J Pharmacol. 2023;941:175493.
    >> Share

    October 2022
  6. GONG Y, Kong B, Shuai W, Chen T, et al
    Effect of sotagliflozin on ventricular arrhythmias in mice with myocardial infraction.
    Eur J Pharmacol. 2022;936:175357.
    >> Share

  7. VAN BAVEL JJA, Beekman HDM, van Weperen VYH, van der Linde HJ, et al
    IKs inhibitor JNJ303 prolongs the QT interval and perpetuates arrhythmia when combined with enhanced inotropy in the CAVB dog.
    Eur J Pharmacol. 2022;932:175218.
    >> Share

    August 2022
  8. SHEN S, Duan J, Hu J, Qi Y, et al
    Colchicine alleviates inflammation and improves diastolic dysfunction in heart failure rats with preserved ejection fraction.
    Eur J Pharmacol. 2022;929:175126.
    >> Share

    July 2022
  9. NOGAWA H, Muraki Y, Kawai T, Kuninishi Y, et al
    Pharmacological characterisation of electrocardiogram J-Tpeak interval in conscious Guinea pigs.
    Eur J Pharmacol. 2022;927:175065.
    >> Share

  10. HAN Y, Xiong C, Zhang LZ, Wang YD, et al
    Antagonism of N/OFQ attenuates externalization of beta1-adrenergic receptor and ventricular arrhythmias in acute myocardial ischemia rat model.
    Eur J Pharmacol. 2022;929:175139.
    >> Share

    June 2022
  11. PONNIAN SMP
    Preventive effects of (-) epicatechin on tachycardia, cardiac hypertrophy, and nuclear factor- kappaB inflammatory signaling pathway in isoproterenol-induced myocardial infarcted rats.
    Eur J Pharmacol. 2022;924:174909.
    >> Share

    January 2022
  12. BALLET V, Bohme GA, Brohan E, Boukaiba R, et al
    In vitro ion channel profile and ex vivo cardiac electrophysiology properties of the R(-) and S(+) enantiomers of hydroxychloroquine.
    Eur J Pharmacol. 2022;915:174670.
    >> Share

    December 2021
  13. THOMET U, Amuzescu B, Knott T, Mann SA, et al
    Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept.
    Eur J Pharmacol. 2021;913:174632.
    >> Share

  14. KILFOIL P, Feng SL, Bassyouni A, Lee T, et al
    Characterization of a high throughput human stem cell cardiomyocyte assay to predict drug-induced changes in clinical electrocardiogram parameters.
    Eur J Pharmacol. 2021;912:174584.
    >> Share

    November 2021
  15. FANG J, Kong B, Shuai W, Xiao Z, et al
    Ferroportin-mediated ferroptosis involved in new-onset atrial fibrillation with LPS-induced endotoxemia.
    Eur J Pharmacol. 2021 Nov 5:174622. doi: 10.1016/j.ejphar.2021.174622.
    >> Share

  16. YANG HW, Lin CY, Lin FZ, Yu PL, et al
    Phosphodiesterase-1 inhibitor modulates Ca(2+) regulation in sirtuin 1-deficient mouse cardiomyocytes.
    Eur J Pharmacol. 2021;910:174498.
    >> Share

  17. JIE LJ, Li YD, Zhang HQ, Mao L, et al
    Mechanisms of gefitinib-induced QT prolongation.
    Eur J Pharmacol. 2021;910:174441.
    >> Share

    September 2021
  18. NAFFAA MM, Al-Ewaidat OA
    Ligand modulation of KCNQ-encoded (KV7) potassium channels in the heart and nervous system.
    Eur J Pharmacol. 2021;906:174278.
    >> Share

  19. GERGS U, Bruckner T, Hofmann B, Neumann J, et al
    The proarrhythmic effects of hypothermia in atria isolated from 5-HT4-receptor-overexpressing mice.
    Eur J Pharmacol. 2021;906:174206.
    >> Share

    August 2021
  20. BELEM-FILHO IJA, Brasil TFS, Fortaleza EAT, Antunes-Rodrigues J, et al
    A functional selective effect of oxytocin secreted under restraint stress in rats.
    Eur J Pharmacol. 2021;904:174182.
    >> Share

    June 2021
  21. BAI S, Wang X, Wu H, Chen T, et al
    Cardioprotective effect of anisodamine against ischemia/reperfusion injury through the mitochondrial ATP-sensitive potassium channel.
    Eur J Pharmacol. 2021;901:174095.
    >> Share

    May 2021
  22. SAPONARA S, Fusi F, Iovinelli D, Ahmed A, et al
    Flavonoids and hERG channels: Friends or foes?
    Eur J Pharmacol. 2021;899:174030.
    >> Share

    April 2021
  23. SILVA EAP, Carvalho JS, Dos Santos DM, Oliveira AMS, et al
    Cardiovascular effects of farnesol and its beta-cyclodextrin complex in normotensive and hypertensive rats.
    Eur J Pharmacol. 2021 Apr 2:174060. doi: 10.1016/j.ejphar.2021.174060.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016